Royal Bank of Canada
EXAS

Royal Bank of Canada’s Exact Sciences EXAS Stock Holding History

Royal Bank of Canada’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-400
Closed -$35K – 6946
2019
Q1 		$35K Buy
400
+300
+300% +$25.5K ﹤0.01% 5361
2018
Q4 		$6K Buy
+100
New +$6.86K ﹤0.01% 6097

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Royal Bank of Canada's EXAS Position: Q1 2026 in Review

Royal Bank of Canada sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 82,548 shares — an estimated $8.38M sold.

Royal Bank of Canada first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $18.8M in Q1 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Royal Bank of Canada reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Royal Bank of Canada sold 82,548 Exact Sciences shares in Q1 2026, an estimated $8.38M.
  • Royal Bank of Canada first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • Royal Bank of Canada's Exact Sciences position peaked at $18.8M in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.